Altex
| 短名 | ALTEX |
| Journal Impact | 4.30 |
| 国际分区 | MEDICINE, RESEARCH & EXPERIMENTAL(Q2) |
| 期刊索引 | SCI Q2中科院 2 区 |
| ISSN | 1868-596X, 1868-8551 |
| h-index | 64 |
| 国内分区 | 医学(2区)医学医学研究与实验(3区) |
ALTEX publishes original articles, short communications, reviews, as well as news and comments and meeting reports. Manuscripts submitted to ALTEX are evaluated by two expert reviewers. The evaluation takes into account the scientific merit of a manuscript and its contribution to animal welfare and the 3R principle.
期刊主页投稿网址| 涉及主题 | 生物医学化学遗传学生物化学计算机科学内科学工程类心理学生态学体外政治学有机化学经济哲学 |
| 出版信息 | 出版商: Springer International Publishing AG，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2000，原创研究文献占比: 92.31%，自引率:17.80%， Gold OA占比: 97.44% |
| 平均审稿周期 | 网友分享经验：平均2月 |
| 平均录用比例 | 网友分享经验：约95% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
ALTEX
2024-3-20
No more monkey business: Advancing personalized medicine with animal-free research - Animalfree Research Forum 2023
2024-1-1
Summer school for systematic reviews of animal studies: Fostering evidence-based and rigorous animal research
2024-1-1
Phase-out planning for animal experimentation: A definition, an argument, and seven action points
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl1
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl2
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl6
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl4
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl7
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl8
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl1
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_suppl3
2024-1-1
Micro-replace systems
2024-1-1
Predicting Acute Oral Toxicity Using AcutoX: An Animal Product-Free and Metabolically Relevant Human Cell-Based Test
2024-1-1
The road to virtual control groups and the importance of proper body-weight selection_suppl
2024-1-1
The importance of variations in in vitro dosimetry to support risk assessment of inhaled toxicants
2024-1-1
A sensitive cell-based assay for testing potency of Botulinum neurotoxin type A
2024-1-1
Revolutionizing developmental neurotoxicity testing – a journey from animal models to advanced in vitro systems
2024-1-1
Characterization and optimization of variability in a human colonic epithelium culture model
2024-1-1
National workshop on alternatives to higher animals in toxicology and biomedical science
2024-1-1
Why adverse outcome pathways need to be FAIR
2024-1-1
Application of microphysiological systems for nonclinical evaluation of cell therapies
2024-1-1
Development of a defined approach for eye hazard identification of solid chemicals according to the three UN GHS categories
2024-1-1
Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis_suppl2
2024-1-1
A sensitive cell-based assay for testing potency of Botulinum neurotoxin type A_suppl
2024-1-1
Sensitivity analysis and quality indicators for an in vitro oral irritation assay_suppl
2024-1-1
Alternative methods go green! Green toxicology as a sustainable approach for assessing chemical safety and designing safer chemicals
2024-1-1
Have the non-technical summaries of animal experiments in Europe improved? An update
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl5
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl7
2024-1-1
Development of a Monoclonal Antibody Sandwich ELISA for the Determination of Antigen Content and Quality in Human and Animal Tetanus Vaccines
2024-1-1
The benefits of validation of methods for toxicity testing outweigh its costs
2024-1-1
The probable future of toxicology - probabilistic risk assessment
2024-1-1
Intestinal in vitro transport assay combined with physiologically based kinetic modeling as a tool to predict bile acid levels in vivo
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl4
2024-1-1
In vitro evaluation of the carcinogenic potential of perfluorinated chemicals
2024-1-1
Developing prototypes of a modernized approach to assess crop protection chemical safety
2024-1-1
Indian Society for Alternatives to Animal Experiments: Sixth annual meeting and international conference
2024-1-1
3 Days for 3Rs 2023: Refinement, reduction, replacement
2024-1-1
Development of a monoclonal antibody sandwich ELISA for the determination of antigen content and quality in diphtheria vaccines
2024-1-1
Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis
2024-1-1
The Implementation Moonshot Project for Alternative Chemical Testing (IMPACT) toward a Human Exposome Project
2024-1-1
Potential value of animal microphysiological systems
2024-1-1
A proof-of-concept rat toxicity study highlights the potential utility and challenges of virtual control groups_suppl
2024-1-1
Elements and development processes for test methods in toxicology and human health-relevant life science research
2024-1-1
3D bioprinting of human skin and squamous cell tumors (SCCs) as advanced models for precision medicine (BIOSQIN)
2024-1-1
Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment_Suppl3
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl5
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_Suppl6
2024-1-1
Risk-based prioritization of PFAS using phenotypic and transcriptomic data from human induced pluripotent stem cell-derived hepatocytes and cardiomyocytes_suppl2
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远